$
Federal Contract Award
Modernatx, INC.
Department of Health and Human Services · April 10, 2025 · FY2025
75A50120C00034Full & OpenNAICS 325414
Obligated
$1,754,345,480
Contract details
- Award ID
- CONT_AWD_75A50120C00034_7505_-NONE-_-NONE-
- PIID
- 75A50120C00034
- Period of performance
- April 3, 2020 → June 15, 2025
- Place of performance
- CAMBRIDGE, MA, USA
- Set-aside
- None (Full & Open)
- Pricing type
- COST PLUS FIXED FEE
- PSC
- AN11 — HEALTH R&D SERVICES; HEALTH CARE SERVICES; BASIC RESEARCH
- NAICS
- 325414 — BIOLOGICAL PRODUCT (EXCEPT DIAGNOSTIC) MANUFACTURING
Scope
DEVELOPMENT OF MRNA VACCINE TO LICENSURE FOR THE PREVENTION OF COVID-19. CLIN 0001 - PRE-AWARD COST, CLIN 0002 - DEVELOPMENT OF MRNA VACCINE TO BLA AND CLIN 0003 - DOMESTIC MANUFACTURING SCALE-OUT
Parent vehicle (IDV)
Modernatx, INC.
UEI WJYNZ8AK2D47
This award was placed as a task/delivery order under a larger contract vehicle.
Awarding agency
Department of Health and Human Services →- Sub-agency
- Office of Assistant Secretary for Preparedness and Response
- Office
- BARDA - ASPR / DAAPPO / BARDA DCMA
- Funding agency
- Department of Health and Human Services
- Funding office
- BARDA - ASPR / DAAPPO / BARDA DCMA
See every contract Modernatx, INC. has won
Full contracting history, year-over-year trends, subaward graph, and recompete alerts.
View Modernatx, INC. profile →